Business Standard

Sunday, December 22, 2024 | 07:41 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

The discontents of decoupling

Economic delinking with China makes no sense for India; investment, growth and public welfare will suffer

Indian drug firms are over-dependent on imported Chinese drug intermediates, or APIs, but Chinese API producers too cannot easily replace India as a key market
Premium

Indian drug firms are over-dependent on imported Chinese drug intermediates, or APIs, but Chinese API producers too cannot easily replace India as a key market

Ravi Bhoothalingam
Two years ago, the United States accused China of using coercive methods to transfer technology from US firms to China, as also of outright theft of know-how. Soon, this quarrel morphed into an overall trade-cum-technology war, with escalating tariffs and political rhetoric at high decibel levels. Ever since, speculation has been rife that we are heading towards a “new normal” in global economic relations — where investment and trade links between the US and China are gradually “decoupled”. Other regions of the world have been drawn in, willingly or unwillingly, and the onset of Covid-19 has aggravated the already heated
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in